A detailed history of Steph & CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Steph & CO holds 10 shares of LLY stock, worth $7,550. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Previous 60 83.33%
Holding current value
$7,550
Previous $54,000 85.19%
% of portfolio
0.0%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$772.14 - $960.02 $38,607 - $48,001
-50 Reduced 83.33%
10 $8,000
Q4 2023

Jan 31, 2024

SELL
$525.19 - $619.13 $16,806 - $19,812
-32 Reduced 34.78%
60 $34,000
Q3 2023

Oct 26, 2023

BUY
$434.7 - $599.3 $5,216 - $7,191
12 Added 15.0%
92 $49,000
Q2 2023

Jul 14, 2023

SELL
$350.74 - $468.98 $7,014 - $9,379
-20 Reduced 20.0%
80 $37,000
Q4 2019

Feb 24, 2020

BUY
$106.92 - $132.43 $10,692 - $13,243
100 New
100 $13,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Steph & CO Portfolio

Follow Steph & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steph & CO, based on Form 13F filings with the SEC.

News

Stay updated on Steph & CO with notifications on news.